G7D (p.Gly7Asp) variant of NCSTN (Nicastrin)
G7D (p.Gly7Asp) in NCSTN (Nicastrin) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.28 / 1. The record also includes structural context.
G7D (p.Gly7Asp) variant details
- p.Gly7Asp
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.28
- REVEL 0.26
- ESM-1b 0.09
- AlphaMissense 0.11
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available